SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-10-025882
Filing Date
2010-02-09
Accepted
2010-02-09 16:30:36
Documents
1
Group Members
CINEASIAS PARTNERS, L.P.F-CUBED PARTNERS, L.P.WHITEBOX COMBINED ADVISORS, LLCWHITEBOX COMBINED FUND, L.P.WHITEBOX COMBINED FUND, LTD.WHITEBOX COMBINED PARTNERS, L.P.WHITEBOX CONCENTRATED CONVERTIBLE ARBITRAGE FUND, L.P.WHITEBOX CONCENTRATED CONVERTIBLE AR

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 1 dsc13ga.htm SC 13G/A 351492
  Complete submission text file 0001193125-10-025882.txt   354207
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Subject) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-12338 | Film No.: 10584759
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 3033 EXCELSIOR BLVD. MINNEAPOLIS MN 55416
WHITEBOX ADVISORS LLC (Filed by) CIK: 0001257391 (see all company filings)

IRS No.: 411957584 | State of Incorp.: DE
Type: SC 13G/A